Pharmacotherapy for Alcohol Dependence in Convicted Drinking Drivers

• Status: Terminated
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This pilot study will explore the ways to link Ontario's remedial system for convicted drinking drivers to medical intervention, assess the receptiveness of the Back on Track client population to effective medical interventions, and assess the feasibility of a full-scale trial of pharmacotherapy for convicted drinking drivers.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre for Addiction and Mental Health
• Treatments: Ethanol; Naltrexone

Criteria

Inclusion Criteria:

• Male or females - 18 years or older

• Been convicted of drinking driving and allocated to either the education or the treatment group of the BOT program

• Meet criteria for alcohol dependence using the SCID-IV

• Consume more than 14 drinks (female) or 21 drinks (male) per week with a minimum of 2 heavy drinking days (≥ 4 drinks for females and ≥ 5 drinks for males) during a consecutive 30-day period within the 90 days prior to the baseline evaluation

• Willing to receive pharmacotherapy for their alcohol dependence

• Seeking abstinence from alcohol as their main goal

Exclusion Criteria:

• History of other substance use (other than nicotine or cannabis) by DSM-IV criteria in the last 90 days (6 months for opiate abuse)

• Positive urine drug screen

• Psychiatric disorder requiring medication

• Unstable medical condition requiring immediate investigation or treatment

• Pregnancy or lactation